Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modeling rare genetic disease with gene-edited induced pluripotent stem cells: relevance of the starting stock line

Stem Cells Translational Medicine(2025)10.1093/stcltm/szaf065Source: DataRank Database

Modeling rare genetic disease with gene-edited induced pluripotent stem cells: relevance of the starting stock line is a research paper published in Stem Cells Translational Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

igsr

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.81)OA: goldTopics (22)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Diane J. Sutcliffe ORCID,Erkin Ozel,Anike Thite,Lauren Grychowski,Jasper E. Visser ORCID

Live enrichment

PubMed:41400570 PMC:PMC12706867 OpenAlex:https://openalex.org/W4417427902

NIH

Grant: NS109242

NIH

Grant: NS119758

Lesch–Nyhan Syndrome Children’s Research Foundation

Lesch-Nyhan Syndrome Children's Research Foundation

Million Dollar Bike Ride

FWCI

0.81

Citation Percentile

0.7%

Citation Trend

2026

goldLicense: cc-by

journalhttps://doi.org/10.1093/stcltm/szaf065

publisherhttps://doi.org/10.1093/stcltm/szaf065

publisherhttps://academic.oup.com/stcltm/article-pdf/14/12/szaf065/65919808/szaf065.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41400570

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12706867

Fields of Study

Biochemical and Molecular ResearchGenomics and Rare DiseasesCRISPR and Genetic Engineering

MeSH Terms

Gene EditingCell LineHumansHypoxanthine PhosphoribosyltransferaseRare DiseasesInduced Pluripotent Stem Cells

Keywords

Induced pluripotent stem cellGenome editingGeneGene expressionGene expression profilingStock (firearms)DiseaseCell cultureHypoxanthine-guanine phosphoribosyltransferaseDisease ModelingHprt1Human Induced Pluripotent Stem CellLesch–nyhan Disease

Modeling rare genetic disease with gene-edited induced pluripotent stem cells: relevance of the starting stock line

FAIR Checklist

Authors (9)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)